We are live on ! Find out more
MEDP icon

Medpace

384 hedge funds and large institutions have $6.23B invested in Medpace in 2021 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 124 increasing their positions, 149 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 19

14% more funds holding

Funds holding: 337 → 384 (+47)

12% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $11.4M

0.17% less ownership

Funds ownership: 79.9% → 79.74% (-0.17%)

5% less capital inflows, than outflows

Capital inflows: $260M | Capital outflows: $272M

17% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 149

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
384
Holders Change
+47
Holders Change %
+13.95%
% of All Funds
5.89%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.06%
New
50
Increased
124
Reduced
149
Closed
19
Calls
$12.8​M
Puts
$11.4​M
Net Calls
+$1.4​M
Net Calls Change
-⁠$6.76​M

MEDP Hedge Fund Activity: Q4 2021 in Review

384 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2021, worth a combined $6.23B — up 15% from $5.42B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new MEDP positions and 19 closed out — a net gain of 31 holders — while 124 added to existing stakes and 149 trimmed.

The largest buyer was Franklin Resources, adding an estimated $44.1M. The largest seller was Aberdeen Group, cutting an estimated $51.8M.

  • 384 institutional investors held Medpace (MEDP) as of Q4 2021, up from 337 in Q3 2021.
  • Funds reported $6.23B of Medpace stock for Q4 2021, up 15% quarter-over-quarter.
  • 50 funds opened new Medpace positions in Q4 2021 and 19 closed out, a net change of +31 holders.
  • The largest Medpace buyer in Q4 2021 was Franklin Resources, an estimated $44.1M added.
  • The largest Medpace seller in Q4 2021 was Aberdeen Group, an estimated $51.8M sold.

Based on aggregated 13F filings for Q4 2021.